Information and impact

Leukaemia
Helping to diagnose rare genetic diseases

Your support helped Professor Kevin Hiom discover a new gene which was involved in the development of a rare genetic disease called Fanconi anemia.

Dario Alessi in the lab
Multiple cancers
Repurposing a diabetes drug for cancer treatment

Your support helped a drug for type 2 diabetes be tested in over 100 clinical trials for treatment and prevention of cancer. 

Professor Hans Clevers
Multiple cancers
Mini tumour organoids to help personalise cancer treatment

You helped fund research that allowed scientists to grow mini tumour organoids in the lab from a patient’s own cancer cells to study the disease and personalise treatment.

Laura Soucek And Team
Lung cancer
Drugging the 'undruggable' target in cancer

A research project you helped fund in 2013 allowed Dr Laura Soucek to develop a new treatment called omomyc, and prove that it was ready for clinical trials.

Stephen Bown With Nurses Anita Agyekum Karikari And Uzma Baqar May 2014
Multiple cancers
Pioneering a new laser therapy for cancer

Our research helped to discover a pioneering new treatment called photodynamic therapy which can cure cancer if it's caught early enough. 

Mark Cragg In Lab
Blood cancer
Helping to develop new blood cancer drugs

Your support helped Professor Mark Cragg discover how drugs could be used to target and destroy cancer cells and helped develop new blood cancer treatments.

Dr Awen Gallimore
Bowel cancer
Clinical trials to stop bowel cancer coming back

Your support in 2005 has helped launch clinical trials testing a promising new treatment option for people with bowel cancer. 

General cancer research
Making the most of your donations to start new cures

How do we know that what we are doing works? We explore the average return on investment of our research funding. 

John Maher Groupshot
Head & neck cancer
Developing a new type of cancer immunotherapy

With your support Dr John Maher's impact on cancer research has led to the development of a brand new type of immunotherapy that is now in clinical trials.